16
Abstract Views
3
PDF Download
Clinical Chemistry

Administration of extract ethanol of Lime peel (Citrus aurantiifolia) effective as anti-hyperlipidaemia: In vivo study

, , , ,
Pages 129-137

Abstract

The quest for natural alternatives to existing pharmaceutical therapies for hyperlipidaemia has been prompted by the known harmful effects of these medications, which are a major risk factor for cardiovascular disease. Lime (Citrus aurantiifolia) peel ethanol extract was tested for its antihyperlipidemic effects on total cholesterol and triglyceride levels in mice that had been hyperlipidaemic due to a high-fat diet. In a genuine experimental study with a pre- and post-test control group design, twenty-five male Mus musculus (ddy strain), two to three months old, weighing twenty to thirty grams each, were split into five groups: one served as a negative control, another as a positive control (simvastatin 0.10 mg/20g BW), and the three treatment groups that received lime peel extract (1, 2, and 2.8 mg/20g BW) were also given a weight. The 96% ethanol maceration process yielded 1.02% of the final extract. Boiling duck egg yolk at a 20% concentration for 14 days caused hyperlipidaemia. There was confirmation of flavonoids by the Shinoda test. Enzymatic colorimetric techniques were used to evaluate lipid levels on both Day 0 and Day 7. Two-Way ANOVA and Tukey's HSD were used for data analysis (p<0.05). Flavonoids were validated by phytochemical screening. Lipid reductions were statistically substantial (p<0.001) across all treatment groups. Similar to simvastatin, the most significant decrease was shown in triglycerides (from 212.8±24.6 to 73.8±5.0 mg/dL) and cholesterol (from 275.2±24.9 to 90.6±5.4 mg/dL) at the optimum dose of 2.8 mg/20g BW. Treatment, time, and their interaction were shown to have significant impacts according to Two-Way ANOVA (p<0.001). With 2.8 mg/20g BW showing excellent antihyperlipidemic action, an ethanol extract of Citrus aurantiifolia peel successfully reduces total cholesterol and triglyceride levels in hyperlipidaemic mice, indicating its promise as a natural treatment option.

There is no Figure or data content available for this article

References

  • 1. Nelson RH. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary Care: Clinics in Office Practice. 2013;40(1):195-211. doi:10.1016/j.pop.2012.11.003
  • 2. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and Cardiovascular Disease. Circulation. 2011;123(20):2292-2333. doi:10.1161/CIR.0b013e3182160726
  • 3. Newman CB, Preiss D, Tobert JA, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2019;39(2). doi:10.1161/ATV.0000000000000073
  • 4. Tirawanchai N, Kengkoom K, Isarangkul D, Burana-osot J. A combination extract of kaffir lime, galangal, and lemongrass maintains blood lipid profiles, hepatocytes, and liver mitochondria in rats with nonalcoholic steatohepatitis. Biomedicine & Pharmacotherapy. 2020;124(January):109843. doi:10.1016/j.biopha.2020.109843
  • 5. Testai L, Calderone V. Nutraceutical Value of Citrus Flavanones and Their Implications in Cardiovascular Disease. Nutrients. Published online 2017:1-13. doi:10.3390/nu9050502
  • 6. Angel M, Flores F, Antonio L, et al. Vascular Health and Risk Management Potential of Fruits to Improve Dyslipidemias : A Pilot Review Potential of Fruits to Improve Dyslipidemias : A Pilot Review. Vascular Health and Risk Managemen. 2025;6344. doi:10.2147/VHRM.S488465
  • 7. Huang H, Liao D, He B, Zhou G, Cui Y. Effects of Citrus Flavanone Hesperidin Extracts or Puri fi ed Hesperidin Consumption on Risk Factors for Cardiovascular Disease : Evidence From an Updated Meta-analysis of Randomized Controlled Trials. Curr Dev Nutr. 2024;8(9):102055. doi:10.1016/j.cdnut.2023.102055
  • 8. Siti HN, Mohamed S, Kamisah Y. Potential Therapeutic Effects of Citrus hystrix DC and Its Bioactive Compounds on Metabolic Disorders. Pharmaceuticals. 2022;15(167).
  • 9. Shwaish MM. Antidiabetic and antihyperglycemic effect of citrus. Int J Health Sci (Qassim). 2022;6(2):8299-8308.
  • 10. Shaikh IA, Muddapur UM, Bagewadi ZK, et al. Characterization of Bioactive Compounds from Acacia concinna and Citrus limon , Silver Nanoparticles ’ Production by. Molecules mdpi. 2022;27(2715):1-15.
  • 11. Steven H. Strogatz. Nonlinear Dynamics And Chaos. 1st ed. CRC Press; 2015.
  • 12. Neovita E, Sari P, Solihah D, Wahyuningsih S, Husnul H, Azhari F. Pengembangan Ekstrak Etanol Kulit Jeruk Lemon ( Citrus limon ( L .)) sebagai Antidiabetes Oral. Jurnal Ilmiah Farmasi. 2020;8(1):1-8. doi:10.26874/kjif.v8i1.220
  • 13. Mutia MS, Ginting CN, Yulizal OK. Suatu Studi Literatur : Aktivitas Antidiabetic Dari Kulit Jeruk ( Citrus Sp . ). Jurnal Maternitas Kebidanan. 2021;6(2):84-92.
  • 14. Minami GS, Lumbantoruan EC, Nuraini R, Carmen J, Review L. The potential of sweet orange (Citrus sinensis) in cardiovascular health: A literature review. Jurnal Kedokteran dan Kesehatan Indonesia literature review. 2023;14(1):82-94. doi:10.20885/JKKI.Vol14.Iss1.art12
  • 15. Mende R, Simbala H, Mansauda KLR. Effctivveness Test Cider And Lime Peel Etanol Extract (Citrus Aurantifolia) Againts Hypercholesterolemia In Male White Rats Galur Wistar (Rattus Norvegicus). Pharmacon. 2021;10:676-683.
  • 16. Maqbool Z, Khalid W, Atiq HT, Koraqi H, Javaid Z, Alhag SK. Citrus Waste as Source of Bioactive Compounds : Extraction and Utilization in Health and Food Industry. Molecules mdpi. 2023;28(1636).
  • 17. El-beltagi HS, Eshak NS, Mohamed HI, Bendary ESA. Physical Characteristics, Mineral Content, and Antioxidant and Antibacterial Activities of Punica granatum or Citrus sinensis Peel Extracts and Their Applications to Improve Cake Quality. Plants mdpi. 2022;11(1740):1-32.
  • 18. Sukandiarsyah F, Hayati DN, Purnamasari V, Riska B. Antioxidant and Anti-inflammatory Activity of Ethanol Extracts from Sambal Orange Peel (Citrus microcarpa Bunge) on Erythrocyte Membrane Stabilization. Indonesian Journal of Chemical Research. 2025;13(2):145-156. doi:10.30598//ijcr
  • 19. Duvbiama D, Adejumo IA, Ishola I, Akinleye M, Oluwatoyin M, Adeyemi OO. The antidiabetic effect of the lime juice ( citrus aurantifolia ) extract of Ficus exasperata in streptozotocin-induced rats. The Nigerian Journal Of Pharmacy. 2023;57(2):602-612.
  • 20. Galle MAC∙ MAL. Citrus reticulata peel oil as an antiatherogenic agent: Hypolipogenic effect in hepatic cells, lipid storage decrease in foam cells, and prevention of LDL oxidation. NMCD Journal. 2020;30(9).
  • 21. E, Lin L yun, Chuang C hung, Chen H chun. Lime ( Citrus aurantifolia (Christm.) Swingle) Essential Oils: Volatile Compounds, Antioxidant Capacity, and Hypolipidemic E ff ect. Foods mdpi. 2019;8(398):1-11.
  • 22. Chen M hung, Yang K min, Huang T chi, Wu M li. Traditional Small-Size Citrus from Taiwan : Essential Oils , Bioactive Compounds and. Medicines mdpi. 2017;4(28):1-11. doi:10.3390/medicines4020028
  • 23. Carvalho BMR, Nascimento LC, Nascimento JC. Citrus Extract as a Perspective for the Control of Dyslipidemia : A Systematic Review With Meta-Analysis From Animal Models to Human Studies. Frontiers in Pharmacology |. 2022;13(February):1-21. doi:10.3389/fphar.2022.822678
  • 24. Akram M, Zahid R, Adetuyi BO, Akinbo O, Adetunji JB. Chapter 30 - Antihyperlipidemic and antioxidant properties of medicinal attributes of essential oil. Academic Press. Published online 2024:327-332. doi:https://doi.org/10.1016/B978-0-323-98340-2.00018-3
  • 25. Ponzo V, Goitre I, Fadda M, et al. Dietary flavonoid intake and cardiovascular risk : a population based cohort study. J Transl Med. 2015;13(218):1-13. doi:10.1186/s12967-015-0573-2
There is no Supplemental content for this article.

How to Cite This

Fahmi, N. F., Anggraini , D. A., Dewi, M. P., Daniati, D., & Nurmansyah , D. (2026). Administration of extract ethanol of Lime peel (Citrus aurantiifolia) effective as anti-hyperlipidaemia: In vivo study . Jurnal Teknologi Laboratorium, 15(2), 129–137. https://doi.org/10.29238/teknolabjournal.v15i2.715

Article Metrics

Download Statistics

Downloads

Download data is not yet available.

Other Statistics

Verify authenticity via CrossMark

Copyright and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Publishing your paper with Jurnal Teknologi Laboratorium (JTL) means that the author or authors retain the copyright in the paper. JTL granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by JTL in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.

JTL journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially.

JTL journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:

  • BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • SA:  If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

Data Availability